# Effects of Continuous Combined Hormone Replacement Therapy and Clodronate on Bone Mineral Density (BMD) in Osteoporotic Women

> **NCT00877097** · NA · COMPLETED · sponsor: **Kuopio University Hospital** · enrollment: 167 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** Klodronate and Kliogest
- **PROCEDURE:** Placebo+ Kliogest
- **DRUG:** Bonefos

## Key facts

- **NCT ID:** NCT00877097
- **Lead sponsor:** Kuopio University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-07
- **Primary completion:** 2002-12
- **Final completion:** 2009-02
- **Target enrollment:** 167 (ACTUAL)
- **Last updated:** 2009-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00877097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00877097, "Effects of Continuous Combined Hormone Replacement Therapy and Clodronate on Bone Mineral Density (BMD) in Osteoporotic Women". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00877097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*